Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
Adies pupil
adverse drug reaction
alpha-fetoprotein
aneurysm, intracranial
angiography, cerebral
apraxia of eye movements
artane
arthralgia
ataxia
ataxia telangiectasia
ataxia, cerebellar
ataxia, truncal
autoimmune disease
autonomic dysfunction
autonomic neuropathy
bacterial infection
basal ganglia, lesion of
basal ganglia, lesion, bilateral
botulinum toxin
bradykinesia
brainstem, infarction of
brainstem, lesion of
burning skin
carcinoembryonic antigen
carcinoma
cardiopulmonary bypass
CAT scan, abnormal
cerebellar ataxia, children
cerebellar ataxia, hereditary
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar lesion
cerebellar pontine angle tumor
cerebrovascular accident, prevention of
children
chorea
chorea, causes of
choreoathetosis
chromosomal abnormality
chromosome 11
cirrhosis
cranial nerve palsies
cranial neuropathy
cranial neuropathy, multiple
deep gray nuclei
diabetes mellitus
differential diagnosis
diplopia
drooling
dysarthria
dyskinesia
dyskinesia, drug induced
dysphagia
dystonia
dystonia musculorum deformens
dystonia, cervical
dystonia, drug induced
dystonia, etiology of
dystonia, evaluation of
dystonia, focal
dystonia, focal lesion causing
dystonia, prevalence of
dystonia, symptomatic
dystonia, treatment of
dystonic reaction, acute
dystonic tremor
ectatic basilar artery
encephalitis
encephalitis, focal
encephalopathy
encephalopathy, metabolic
epidemiology of neurology
eye movement, disorders of
facial nerve palsy
familial
fatigue
fungal infection, CNS
gene
gene mutation
genetic linkage
genetic neurologic disorders
globus pallidus, stimulation
grimacing
growth retardation
hearing loss
hemifacial spasm
hepatolenticular degeneration(Wilson's disease)
hydrocephalus
hypertension
hypotonia
hypoxia
immunodeficiency
immunosuppression
iron, brain
L-dopa
leukemia
lymphoma
manganese intoxication
meningitis
mental retardation
metabolic disorder, primary
mimics
misdiagnosis
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, eye of tiger sign
MRI, FLAIR
MRI, high signal foci on
MRI, high signal intensity of basal ganglia
MRI, paramagnetic effect
MRI, serial
MRI, T1 weighted high signal foci
multiple system atrophy
muscle pain
neurocutaneous disease
neuroendocrinology
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neuropathology
neuropathy
neurotoxin
ocular motility, disorders of
optic neuropathy
PANK2 mutation
Parkinsonism syndrome
pathology
polycythemia, primary
polycythemia, secondary
polymyositis
pons, infarction of
pons, lesion of
progeria
prognosis
psychiatric problems in neurologic disorders
pupil, abnormality in neurologic disorders
pupil, tonic
radiation hypersensitivity
review article
sedimentation rate, elevated
seizure
sensorineural hearing loss
sicca syndrome
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
skin, lesions in neurologic disorders
spinal cord, lesion of
spinal muscular atrophy
stimulation, deep brain
striatum, lesion of
striatum, lesion of, bilateral
subarachnoid hemorrhage
symmetric brain lesions
telangiectases
thalamic dystonia
thalamus, lesion of
toxins, nervous system
transient ischemic attack
treatment of neurologic disorder
trigeminal neuralgia
vertebral-basilar insufficiency
viral infection
viral infection, CNS
walking, difficulty with
wheelchair
white matter disease
writers cramp
xerophthalmia
xerostomia
Showing articles 600 to 650 of 1357 << Previous Next >>

Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000

Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in patients at High Risk of Vascular Disease?
Stroke 31:1779-1784, Hankey,G.J. et al, 2000

C1/C2 Rotary Subluxation Due to Spasmodic Torticollis
JNNP 69:135-136, Dalvie,S. et al, 2000

Pravastatin Therapy and The Risk of Stroke
NEJM 343:317-326, White,H.D. et al, 2000

Whole Grain Consumption and Risk of Ischemic Stroke in Women
JAMA 284:1534-1540, Liu,S. et al, 2000

Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000

New Transient Ischemic Attack and Stroke
Arch Int Med 160:2941-2946, Goldstein,L.B.,et al, 2000

Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000

Hemidystonia and Hemichoreoathetosis as an Initial Manifestation of Moyamoya Disease
Arch Neurol 57:1510-1512, Lyoo,C.H.,et al, 2000

Intake of Flavonoids, Carotenoids,Vitamins C and E, and Risk of Stroke in Male Smokers
Stroke 31:2301-2306, Hirvonen,T.,et al, 2000

Effect of Contralateral Occlusion on Long-Term Efficacy of Endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS)
Stroke 31:2330-2334, Baker,W.H.,et al, 2000

Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000

Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000

Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000

Pallidal Stimulation for Generalized Dystonia
J Neurosurg 92:453-456, Tronnier,V.M. &Fogel,W., 2000

Intrathecal Baclofen for the Treatment of Dystonia in Patients with Reflex Sympathetic Dystrophy
NEJM 343:625-630,654, van Hilten,B.J. et al, 2000

Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000

Long-Term Clinical and Angiographic Outcomes in Symptomatic Patients with 70% to 99% Carotid Artery Stenosis
Stroke 31:2037-2042, Paciaroni,M. et al, 2000

Carotid Endarterectomy, A Neurotherapeutic Advance
Arch Neurol 57:40-45, Barnett,H.J.M.&Meldrum,H.E., 2000

AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000

Physical Activity and Stroke Mortality in Women, Ten-Year Follow-Up of the Nord-Trondelag Health Survey, 1984-1986
Stroke 31:14-18, Ellekjaer,H.,et al, 2000

Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000

Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000

Cerebral Venous Thrombosis Associated with Epoetin Alfa Therapy
Arch Neurol 57:260-262, Finelli,P.F.&Carley,M.D., 2000

Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000

HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000

Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000

Frequency of the DYT1 Mutation in Primary Torsion Dystonia Without Family History
ArchNeurol 57:333-335, Brassat,D.,et al, 2000

Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000

Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000

Physical Activity and Risk of Stroke in Women
JAMA 283:2961-2967, Hu,F.B.,et al, 2000

Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000

North Carolina Stroke Prevention and Treatment Facilities Survey
Stroke 31:66-70, Goldstein,L.B.,et al, 2000

Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000

The DYT1 Phenotype and Guidelines for Diagnostic Testing
Neurol 54:1746-1753,1718, Bressman,S.B.,et al, 2000

Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000

Secondary Prevention of Transient Ischaemic Attack and Stroke
BMJ 320:991-994, Lees,K.R.,et al, 2000

Results of Radiosurgery for Brain Stem Arteriovenous Malformations
JNNP 68:563-570,548, Kurita,H.,et al, 2000

Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000

Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000

The Protective Effect of Moderate Alcohol Consumption on Ischemic Stroke
JAMA 281:53-60,104, Sacco,R.L.,et al, 1999

Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999

Exercise and Risk of Stroke in Male Physicians
Stroke 30:1-6, Lee,I-M.,et al, 1999

Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly
Arch Int Med 159:38-44, Bots,M.L.,et al, 1999

Risk Factor Modification in Stroke Prevention,The Experience of a Stroke Clinic
Stroke 30:16-20, Joseph,L.N.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Oral Anticoagulation in Patients with Atrial Fibrillation:Adherence with Guidelines in an Elderly Cohort
Am J Med 106:165-171, White,R.H.,et al, 1999

Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999

Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999

Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999



Showing articles 600 to 650 of 1357 << Previous Next >>